MLS® and COVID-19: a new success in treating interstitial pneumonia

02 October 2020 - Research -

A new case confirms the effectiveness of MLS® as supporting therapy for treating pneumonia caused by COVID-19.

An obese patient with interstitial pneumonia who was treated for 4 days with MLS® Laser Therapy reported a concrete and progressive improvement in her critical parameters such as oxygen saturation, which increased to 97-99%, radiographic assessment of the pulmonary oedema (RALE) which went from 8 to 2, Brescia-COVID Respiratory Severity Scale (a score which assesses the gravity of the pneumonia and is used for patient progress management) which went from 4 to 0 and SMART-COP (a tool which monitors the seriousness of the pneumonia and predicts the need for intervening such as with a move to intensive care, etc.) which dropped from 5 to 1. Interleukin-6, ferritin and C-reactive protein also recorded a significant contraction.

The data were reported by the study “Adjunct low level laser therapy (LLLT) in a morbidly obese patient with severe COVID-19 pneumonia: A case report” whose conclusions indicate that use of MLS® Laser Therapy for the case in question recorded a significant improvement of the respiratory indexes, radiological results and inflammatory markers in just a few days.

A result which suggests that ASA’s therapy can safely be combined with conventional treatment for patients suffering from severe COVID-19 and morbid obesity.

Max 980px
Blog - obese patient with severe COVID-19 pneumonia assessment

You might also be interested in ...

See all articles

press - 01/09/2020
The NBC Boston News channel presents an important case report which demonstrates how MLS® Laser Therapy, applied to a patient affected by Covid-19 in order to treat pulmonary infection, markedly...
MLS Laser Therapy for the treatment of COVID19 pneumonia
blog - 24/08/2020
A very recent case report concerning the use of MLS® Laser Therapy supporting a patient suffering from severe pneumonia caused by Covid-19 reported a significant improvement in some basic parameters...
MLS Laser Therapy in a morbidly obese patient with severe COVID-19 pneumonia
S.A. Sigman, S. Mokmeli, M.A. Vetrici Canadian Journal of Respiratory Therapy, 56:52–56, 2020
ASA laserterapia en la Universidad Autonoma de Chile
News - 12/05/2022
The Universidad Autónoma de Chile and the Universidad Andrés Bello hosted two in-depth sessions dedicated to MLS® Laser Therapy as part of two seminars entitled respectively “Physical agents: the...
Press - 03/05/2022
"We have treated almost 40 patients with laser therapy and all of them have experienced an improvement in their condition” - Jana Mahdalíková
MLS Laser Therapy for Hypoxia/Ischemia-Induced Rod Microglia
Blog - 20/04/2022
This study lays the foundations for many research perspectives in the field of photobiomodulation using near infrared laser radiation (NIR) and demonstrates the effectiveness of MLS® and its MiS...